Phase I Study of GS-3583, an FMS-like Tyrosine Kinase 3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors
Tolcher, Anthony W., Brody, Joshua D., Rajakumaraswamy, Nishanthan, Kuhne, Michelle, Trowe, Torsten, Dauki, Anees M., Pai, Shantheri, Han, Ling, Lin, Kai-Wen, Petrarca, Michael, Kummar, Shivaani
Published in Clinical cancer research (15.07.2024)
Published in Clinical cancer research (15.07.2024)
Get full text
Journal Article
Phase 1b dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of GS-3583, a FLT3 agonist Fc fusion protein, in patients with advanced solid tumors
Brody, Joshua, Thompson, John A., Tolcher, Anthony W., Kuhne, Michelle R., Huang, Xi (Rochelle), Kwan, Ellen, Petrarca, Michael, Dauki, Anees, Singh, Indrajeet, Rajakumaraswamy, Nishanthan, Kummar, Shivaani
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Phase I Study of GS-3583, a FLT3 Agonist Fc Fusion Protein, in Patients with Advanced Solid Tumors
Tolcher, Anthony W, Brody, Joshua D, Rajakumaraswamy, Nishanthan, Kuhne, Michelle, Trowe, Torsten, Dauki, Anees M, Kochikar Pai, Shantheri, Han, Ling, Lin, Kai-Wen, Petrarca, Michael, Kummar, Shivaani
Published in Clinical cancer research (31.01.2024)
Get full text
Published in Clinical cancer research (31.01.2024)
Journal Article
CC-122, a Novel Cereblon Modulating Agent, in Combination with Obinutuzumab (GA101) in Patients with Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)
Michot, Jean-Marie, Bouabdallah, Reda, Doorduijn, Jeanette K., Vitolo, Umberto, Kersten, Marie José, Chiappella, Annalisa, Zinzani, Pier Luigi, Sarmiento, Rafael, Mosulen, Silvia, Mendez, Cristina, Petrarca, Michael, Pourdehnad, Michael, Hege, Kristen, Li, Li, Nikolova, Zariana, Ribrag, Vincent
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
CC-122 DLBCL-001: Phase Ib Study of CC-122 Plus Rituximab in Patients with Chemo-Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Ribrag, Vincent, Chavez, Julio C., Vitolo, Umberto, Kaplan, Jason B., Chandler, Jason C., Santoro, Armando, Corradini, Paolo, Flinn, Ian W., Nastoupil, Loretta, Cassier, Philippe A., Sangha, Randeep, Kenkre, Vaishalee P., Advani, Ranjana H., Isufi, Iris, Witzig, Thomas E, Petrarca, Michael, Hagner, Patrick R., Gandhi, Anita K., Wu, Xiaoling, Hege, Kristen, Pourdehnad, Michael, Kuruvilla, John
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
BELLOWS WITH CONTROLLED SHIFT OF MEAN EFFECTIVE DIAMETER
RUGGERI, Edward Nicholas, BENDER, Steven Paul, PETRARCA, Michael Christopher, LAVIN, Jeffrey Robert, BERARD, Gerald Maurice
Year of Publication 17.07.2024
Get full text
Year of Publication 17.07.2024
Patent
BELLOWS WITH CONTROLLED SHIFT OF MEAN EFFECTIVE DIAMETER
Ruggeri, Edward Nicholas, Bender, Steven Paul, Petrarca, Michael Christopher, Berard, Gerald Maurice, Lavin, Jeffrey Robert
Year of Publication 11.07.2024
Get full text
Year of Publication 11.07.2024
Patent